Google and Sanofi Team Up
The tech giant and pharmaceutical manufacturer are hoping to develop new solutions together.
Sanofi and Google have announced that they are collaborating on the creation of a virtual innovation lab to develop scientific and commercial solutions.
With the collaboration, Sanofi hopes to change how it develops treatments. The collaboration will feature three key objectives:
- to better understand patients and diseases
- to increase Sanofi’s operational efficiency
- to improve the experience of Sanofi’s patients and customers
Related: Personalized Care Core Of Rite-Aid-Adobe Partnership
Sanofi will be utilizing Google’s deep analytics to better understand diseases and insights on patients, potentially allowing for more personalized treatments as Sanofi gains deeper understanding of how treatments work.
The partnership will also enable the use of AI to forecast sales and help to inform marketing and supply chain efforts. The AI will use real-time information to track geographic, logistic, and manufacturing issues and help to increase accuracy in those areas.
All of this, Sanofi says, will allow the drug manufacturer to optimize patient care and lower healthcare costs.
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
